Acetaminophen (Tylenol) for Mood and Memory Changes Associated With Corticosteroid Therapy

PHASE4CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

November 30, 2006

Primary Completion Date

October 31, 2008

Study Completion Date

October 31, 2008

Conditions
AsthmaRheumatic Disease
Interventions
DRUG

Drug: Acetaminophen, Drug: Placebo

Acetaminophen: Participants will be given acetaminophen (two 500 mg tablets) four times daily for 7 days, not exceeding 4,000 mg/day. Placebo: Participants will be given placebo(two 500 mg tablets) four times daily for 7 days

Trial Locations (1)

75390

UT Southwestern Medical Center at Dallas, Dallas

All Listed Sponsors
collaborator

McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.

INDUSTRY

lead

University of Texas Southwestern Medical Center

OTHER

NCT00377364 - Acetaminophen (Tylenol) for Mood and Memory Changes Associated With Corticosteroid Therapy | Biotech Hunter | Biotech Hunter